latest news releases from the newsroom
XsunX Ends the Year on a High Note
ALISO VIEJO, Calif., Dec. 13, 2004 (PRIMEZONE) -- XsunX, Inc. (OTCBB:XSNX), developer of Power Glass(TM) -- an innovative solar technology that allows glass windows to produce electricity from the power of the sun, today announced the launch of the company's new Website, www.xsunx.com
Discovery Laboratories, Inc.
Treatment with Surfaxin(r) Supports Improved Survival of Premature Babies
WARRINGTON, Pa., Dec. 13, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) presented additional clinical data from their primary Phase 3 study, the SELECT trial at the 2004 Annual Hot Topics in Neonatology meeting in Washington, DC on Sunday, December 12. Top line data previously reported from Discovery's pivotal multinational SELECT study showed that prophylactic Surfaxin(r) (lucinactant) therapy increased survival of premature babies with Respiratory Distress Syndrome (RDS) compared with comparator surfactant replacement therapies. In addition, when treated with Surfaxin, more babies survived without developing debilitating chronic lung disease, also known as bronchopulmonary dysplasia (BPD), compared with those treated with Exosurf, a non-protein containing synthetic surfactant.
First Horizon National Corporation
First Horizon Expands Commercial Banking Services in Georgia
ATLANTA, Dec. 13, 2004 (PRIMEZONE) -- Georgia business leaders seeking corporate banking services for companies with revenue between $20 and $500 million have a new resource with the opening of the Atlanta office of First Horizon Corporate Financial Services. The office is part of First Horizon National Corp. (NYSE:FHN) and expands the Southeast team of First Horizon Corporate Financial Services. Other offices are located in Winston-Salem and Charlotte, N.C.